For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.
Despite being chronic inflammatory skin diseases, atopic dermatitis, psoriasis, and chronic urticaria have differing management algorithms that may benefit from standardization.
Eucrisa (crisaborole) ointment, 2%, is now approved for the treatment of mild to moderate atopic dermatitis in pediatric patients as young as 3 months old.
Treatment with dupilumab in patients with moderate to severe atopic dermatitis was found to be effective in 54% of patients—a percentage that may reflect use of adjunctive therapies.
Preventative measures and meticulous care of intravascular catheters and their placement, should keep the mortality rate from S. aureus low in patients with atopic dermatitis.
Insights into prescribing patterns of European dermatologists in treating atopic eczema reveal use of conventional photo- and systemic therapies and shows a preference for off-label therapies.
An atopy patch test with aeroallergens could be a beneficial clinical tool to help increase correct diagnosis of allergens in patients with allergic skin and respiratory diseases.
